Sign in
4

Changes in Ownership

ANI PHARMACEUTICALS INC Filed Acc 0001104659-23-083131

HEAD OF R&D, COO-NOVITIUM OPS sold 23,469 shares at an average $52.02 ($1,220,844)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Shanmugam Muthusamy · HEAD OF R&D, COO-NOVITIUM OPS

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-19 Sale : show line 1 in the form 10b5-1 −5,969 $51.48 $307,284 1,250,120 I
2023-07-20 Sale : show line 2 in the form 10b5-1 −6,000 $51.52 $309,120 1,244,120 I
2023-07-21 Sale : show line 3 in the form 10b5-1 −11,500 $52.56 $604,440 1,232,620 I
Open-market sales · 23,469 sh · avg $52.02 · $1,220,844
Loading xslF345X05/tm2321830-1_4seq1.xml…